ProfileGDS5678 / 1432748_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 12% 8% 8% 8% 8% 8% 8% 8% 9% 8% 8% 8% 8% 8% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.3334512
GSM967853U87-EV human glioblastoma xenograft - Control 22.1848
GSM967854U87-EV human glioblastoma xenograft - Control 32.18928
GSM967855U87-EV human glioblastoma xenograft - Control 42.142568
GSM967856U87-EV human glioblastoma xenograft - Control 52.148148
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.226948
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.19628
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.163528
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.195599
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.174558
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.168978
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.168148
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.178418
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.175668